Greenwich LifeSciences, Inc. (GLSI)
19.53
-1.48
(-7.04%)
USD |
NASDAQ |
Jan 02, 16:00
19.50
-0.03
(-0.15%)
After-Hours: 17:44
Greenwich LifeSciences EPS Diluted (Quarterly): -0.3044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.152M |
| Total Expenses (Quarterly) | 4.152M |
| Enterprise Value | 287.28M |
| Earnings Yield | -7.50% |
| Normalized Earnings Yield | -7.497 |